One advantage of gemfibrozil (Lopid) is that, in addition to lowering blood levels of most lipids, it raises the level of HDL cholesterol. This consideration is:

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan ATI Questions

Question 1 of 5

One advantage of gemfibrozil (Lopid) is that, in addition to lowering blood levels of most lipids, it raises the level of HDL cholesterol. This consideration is:

Correct Answer: A

Rationale: In this scenario, the correct answer is A) TRUE. Gemfibrozil, also known as Lopid, is a fibric acid derivative commonly used to lower blood lipid levels. One advantage of gemfibrozil is that it not only decreases levels of most lipids but also increases HDL cholesterol levels. This is important because HDL cholesterol is known as "good" cholesterol as it helps remove LDL cholesterol (the "bad" cholesterol) from the arteries, reducing the risk of heart disease. Option B) FALSE is incorrect because gemfibrozil does indeed raise HDL cholesterol levels, as stated above. Option C) None and Option D) All the above are also incorrect as they do not accurately reflect the specific advantage of gemfibrozil in relation to HDL cholesterol. From an educational standpoint, understanding the effects of different medications on lipid profiles is crucial in pharmacology. Knowing that gemfibrozil can raise HDL cholesterol levels is important for healthcare providers when prescribing medications to manage lipid disorders and reduce cardiovascular risk in patients. This knowledge helps in making informed decisions to optimize patient outcomes and prevent complications related to dyslipidemia.

Question 2 of 5

Probucol (Lorelco) reduces the risk of atherosclerosis by stimulating the rate of clearance of LDL by receptor-mediated pathways. This consideration is:

Correct Answer: B

Rationale: In this question, the correct answer is B) FALSE. Probucol (Lorelco) actually reduces the risk of atherosclerosis by inhibiting the oxidation of LDL cholesterol rather than by stimulating the rate of clearance through receptor-mediated pathways. The incorrect options can be explained as follows: A) TRUE - This option is incorrect because, as mentioned earlier, Probucol works by inhibiting LDL oxidation, not by stimulating its clearance via receptor-mediated pathways. C) All of the above - This option is incorrect as it implies that both the statement in the question and its opposite are correct, which is not the case. D) None of the above - This option is also incorrect because the statement in the question is false. From an educational perspective, understanding the mechanisms of action of pharmacological agents is crucial for healthcare professionals to make informed decisions regarding patient care. In this case, knowing that Probucol acts by inhibiting LDL oxidation helps healthcare providers understand how it reduces the risk of atherosclerosis. This knowledge can guide appropriate prescribing practices and patient education efforts to optimize therapeutic outcomes.

Question 3 of 5

This fibric acid derivative increases blood levels of high density lipoproteins (HDL):

Correct Answer: C

Rationale: In this question, the correct answer is C) Gemfibrozil (Lopid). Gemfibrozil is a fibric acid derivative that works by increasing the levels of high-density lipoproteins (HDL) in the blood. HDL is considered the "good" cholesterol as it helps remove LDL (low-density lipoproteins) or "bad" cholesterol from the bloodstream, reducing the risk of cardiovascular diseases. Option A) Cholestyramine (Questran) is a bile acid sequestrant that works by binding to bile acids in the intestine, leading to increased excretion of cholesterol. It does not increase HDL levels. Option B) Lovastatin (Mevacor) is a statin medication that works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. Statins primarily lower LDL cholesterol levels and have a modest effect on increasing HDL levels. Option D) Probucol (Lorelco) is a cholesterol-lowering medication that mainly works by decreasing LDL levels and has minimal impact on raising HDL levels. Educationally, understanding the mechanism of action of different lipid-lowering medications is crucial for healthcare professionals to make informed decisions when managing patients with dyslipidemia. Knowing which medications target specific lipid profiles, such as increasing HDL levels, helps in individualizing treatment regimens for better patient outcomes.

Question 4 of 5

Uricosuric drugs are the following, EXCEPT:

Correct Answer: C

Rationale: Uricosuric drugs are medications that increase the excretion of uric acid in the urine, thus reducing its levels in the body. In this case, colchicine is the correct answer as it is not a uricosuric drug. Colchicine is actually used to treat gout by reducing inflammation and pain associated with the condition, but it does not directly lower uric acid levels. Probenecid and sulfinpyrazone are uricosuric drugs commonly used to treat gout by increasing the excretion of uric acid. Aspirin, when used at high dosages, can actually decrease the excretion of uric acid and lead to increased levels in the body, making it an incorrect choice in this context. Educationally, understanding the mechanism of action of different drugs used in the treatment of gout is crucial for healthcare professionals. Knowing which drugs lower uric acid levels directly (uricosuric drugs) and which ones act through other mechanisms helps in making informed decisions regarding treatment plans for patients with gout. This knowledge ensures safe and effective pharmacological management of patients across the lifespan.

Question 5 of 5

Estrogens can prevent accelerated bone loss during the immediate postmenopausal period and at least transiently increase bone in the postmenopausal subject. This consideration is:

Correct Answer: A

Rationale: The correct answer is A) TRUE. Estrogens play a crucial role in maintaining bone health in women. During the immediate postmenopausal period, when estrogen levels drop significantly, women are at increased risk of accelerated bone loss, leading to conditions like osteoporosis. Estrogen therapy can help prevent this bone loss and even increase bone density temporarily in postmenopausal women. Option B) FALSE is incorrect because the statement provided in the question is actually true, as explained above. Option C) All of the above and Option D) None of the above are also incorrect as they do not accurately reflect the situation described. From an educational perspective, understanding the role of estrogens in bone health is vital for healthcare professionals, especially those working with women across the lifespan. By recognizing the significance of estrogen in preventing bone loss, healthcare providers can make informed decisions regarding hormone therapy and other interventions to support bone health in menopausal and postmenopausal women. This knowledge is essential for promoting overall well-being and quality of life in this population.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions